IRON AMINOS CAGRILINTIDE 10MG
Research-grade amylin-pathway peptide prepared for consistency and clear documentation in professional lab workflows.
Key Features
-
10mg cagrilintide per vial (lyophilized powder)
-
≥99% purity for reproducible results
-
Sterile, sealed glass vial with tamper-evident flip cap
-
Lot and batch labeling for traceability
-
Signature Iron Aminos red-honeycomb label for quick identification
-
Diluent not included
Specifications
-
Compound: Cagrilintide
-
Class/Target: Long-acting amylin receptor agonist (calcitonin receptor + RAMP complexes)
-
Form/Appearance: Lyophilized powder, white to off-white
-
Amount: 10mg per vial
-
Purity: ≥99%
-
Storage (lyophilized): Cool, dry, away from light
-
Storage (after reconstitution): Refrigerate and use promptly per internal SOP
What’s Included
-
1 × Cagrilintide 10mg vial (no diluent)
Handling
Use an appropriate sterile diluent and aseptic technique. Follow your lab SOPs for reconstitution, aliquoting, labeling, and disposal.
Research Snapshot
-
Amylin receptor agonism has been shown to reduce energy intake and body weight in preclinical models and randomized human studies, with effects attributed to enhanced satiety and delayed gastric emptying.
-
Cagrilintide is an acylated, long-acting analog designed for extended exposure in once-weekly study protocols via albumin binding.
-
Combination protocols pairing an amylin-pathway agonist with a GLP-1 receptor agonist have reported additive weight-loss effects versus either agent alone in clinical trials.
-
The most common study-reported adverse events are gastrointestinal, including nausea and vomiting, typically mitigated by dose titration.
-
Cagrilintide remains investigational and is not approved for medical use.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
